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Introduction
complement and monocyte activation. In addition, changes in proinflammatory cytokine synthesis and Patients with end-stage renal failure undergoing chronic secretion (IL1, IL6, TNF-a) and rise in acute phase renal replacement therapy reveal several signs of an reactants revealing inadequate 'immunostimulation' impaired humoral and cellular immune response [1, 2] . apparently contribute to progressive atherosclerotic As a consequence patients are more susceptible to bac-lesions and increased cardiovascular events [3, 4] . terial infections, exhibit defective phagocytosis, altered
Monocytes are closely involved in antigen presenta-B-/T-cell and disturbed killer cell activity, low response tion, T-and B-cell cooperation and secretion of various rate to hepatitis B vaccine, and increased risk for cancer. monokines, and play a pivotal role not only as targets On the other hand, secondary immunodeficiency in in biocompatibility but are also responsible for microchronic uraemia is masked by dialysis-related blood-inflammation and the dysbalance of the immune system observed in chronically uraemic patients [5, 6 ] .
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petence addressed above. In addition, recent clinical work of our group on major monocyte differentiation concentration was significantly higher in 115 HIV and activation antigens is summarized. The data stress patients and depended from CDC-classification [13] . the importance of distinct blood monocyte populations
In patients with end-stage renal failure who were and the soluble and membrane bound monocyte endo-treated by intermittent haemodialysis sCD14 was signitoxin receptor CD14 as biological markers for screen-ficantly augmented (5.5 mg/l vs, 2.2 mg/l, P<0.0001) ing and monitoring inflammatory disease activity [7] . [6, 7] . In dialysis patients with either acute or chronic infections a further rise in sCD14 levels emerged [8, 11] . These data suggest suggest that increased serum levels CD14, a major monocyte receptor antigen of sCD14 reflect an activated status of monocytes or macrophages and result from increased membrane Peripheral blood monocytes carry a glycoprotein, the shedding. myeloid differentiation antigen CD14, with a molecular weight of 53 kDa, which is attached to the cell mem-CD14+/CD16+ monocytes: the proinflammatory brane by a glycophosphatidyl-inositol anchor. The CD14 molecule is not only a major surface receptor subset for lipopolysaccharide (LPS, endotoxin) but also for lipoteichonic acid, peptidoglycans and phospholipids Blood monocytes represent a heterogeneous cell from Gram-positive bacteria, thus indicating that population [10] . At least two populations can be dis-CD14 acts as a multifunctional molecule. Furthermore, tinguished depending on the expression pattern of the CD14 antigen is involved in recognition and membrane surface antigens, release of cytokines and phagocytosis of apoptotic cells. In cooperation with phagocytic activity. Most, if not all, blood monocytes a LPS-binding protein (LBP), LPS upregulates CD14 express the endotoxin receptor antigen CD14, which expression, whereas immunosuppressive drugs down-differs in its cell surface density. modulate the antigen [8,9]. Activated monocytes
The major fraction of monocytes is strongly positive secrete various cytokines, enzymes and free oxygen for CD14 (CD14++), however, it lacks coexpression radicals. Patients suffering from non-infectious with Fcc receptor III, the CD16 antigen. CD16, a low diseases, e.g. systemic vasculitis, or from aberrant affinity IgG Fc-receptor, together with complement immunoregulatory diseases disclosed an activation of plays an important role in immune-complex mediated blood monocytes via CD14, which is also released from tissue injury. Leucocytes deficient for CD16 lack IgG the cells in a soluble form (sCD14) at an increased mediated mast cell activation, show diminished Arthus rate. Furthermore, a subset of CD14+ monocytes reaction, resistance to cryoglobulin-associated vasculcoexpresses CD16, a Fcc receptor type III, and selectively itis, and passive anaphylaxis. Furthermore, CD16 is expands under acute and chronic inflammatory clinic-involved in the onset of autoantibody mediated disease, ally defined conditions [10, 11] .
and animals lacking the antigen do not develop immune-complex induced glomerulonephritis. Blood monocytes expressing both the CD14+ and
Soluble CD14 (sCD14)
CD16+ antigen constitute a proinflammatory subtype, which exhibit features of tissue macrophages. We analysed the serum concentrations of sCD14 in CD14+/CD16+ monocytes and sCD14 were highly patients with systemic lupus erythematosus [12] . The increased in patients with infectious and non-infectious following three clinical groups were assessed for inflammatory diseases [7, 8, 11] . They also disclosed an sCD14, soluble IL-2-receptor (sIL-2r), IL-1b, antinuc-augmented HLA-DR expression and phagocytic activlear antibodies (ANA), anti-ds-DNA antibodies, and ity compared to CD14+/CD16 negative cells. CD14+ complement C3: (i) 65 healthy volunteers, (ii) 35 (and CD68+) cells accumulated up to 10-fold in patients with an inactive phase of systemic lupus kidneys of patients with progressive renal disease and erythematosus (SLE ) and (iii) 17 patients with SLE in kidney allografts with chronic dysfunction, as shown relapses. Disease activity was scored according to the by immunohistochemistry and image analysis [7] . As sensitive activity index reported by Isenberg [for details expected, in patients infected with HIV, the expression see ref. 12]. In healthy controls sCD14 levels were of CD14 on blood monocytes and the percentage of 2.18±0.46 mg/l (median 2.1 mg/l ). They were signi-CD14+/CD16+ monocytes also increased significficantly higher in patients with inactive SLE (median antly and paralleled disease state [13] . 4.1 mg/l, P<0.0001 vs controls). Patients with clinically active SLE revealed even higher serum concentrations of sCD14 (median 6.9 mg/l, P<0.001). SCD14 Monocyte phenotypes in patients undergoing levels did not correlate with the amount of blood intermittent haemodialysis (HD) monocytes and IL-1b. A close correlation emerged Blood monocytes are engaged in primary host defence between SLE activity score and sCD14, C3 and sIL-2r, against infections. We assessed the expression of the but not with IL-1b and anti-ds-DNA titers.
monocyte CD14 antigen as well as the presence of a Longitudinal studies revealed that serum sCD14 parminor subpopulation coexpressing low levels of CD14 alleled the clinical course as defined by the above together with CD16 in haemodialyzed patients [6, 11] . activity score. In a similar manner, as an example for Mean CD14 expression of total blood monocytes from chronic viral disease, compared to 78 normal controls sCD14 (median 2.2 mg/l ) the mean sCD14 serum HD patients was significantly lower compared to normal controls and uraemic patients not yet requiring dialysis Activated monocytes and drug response treatment (P<0.0001). Since the amount of CD14 per cell is positively correlated with endotoxin (LPS) bind-We monitored various monocyte markers in patients ing to the monocyte surface also processing of LPS and with acute vasculitis before and after pulse therapy cytokine synthesis and release is altered in haemodialysis with glucocorticoids [8, 9] . Glucocorticoids caused patients. Chronic intermittent 'stimulation' of mono-rapid clinical improvement, that is, rise in glomerular cytes by LPS or LPS-like substances during dialysis filtration rate, decrease of proteinuria, drop of acute may finally result in low CD14-expression due to phase reactants etc. In parallel, elevated serum sCD14, enhanced shedding of the antigen. Endotoxins and low monocyte expression of CD14 (−35%) and HLA-DR (−60%) decreased. Cultured monocytes from healthy molecular weight LPS-fragments, not detectable by conpeople dramatically upregulated membrane CD14 and ventional tests, can enter the blood across the haemodiarelease of sCD14 in the presence of LPS [9] . LPSlysis membrane by diffusive and convective transfer [5] binding capacity of FITC-labelled LPS from E. coli and prime cytokine release [14] .
was directly correlated with monocyte CD14 expresIn healthy controls CD14+/CD16+ monocytes sion (r=0.89, P<10−4). Endotoxin-induced stimulaaccount for 8% of all CD14+ monocytes only.
tion of CD14 and sCD14 synthesis was markedly but However, in stable HD patients the CD14+/CD16+ not completely abolished by glucocorticoids such as subpopulation was significantly elevated (14±3% or hydrocortisone, prednisolone and dexamethasone 66±28 cells/ml ) while CD14++ monocytes remained (10−4-10−9 M ) following a sigmoid curve dose constant [7, 11] . In HD patients suffering from infection dependency. In addition, glucocorticoids significantly a further rise in CD14+/CD16+ monocytes was decreased the secretion of IL-1b of LPS activated observed (128±71 cells/ml, P<0.01) and contributed monocytes. However, no changes of CD35, HLA-DR to 24% of all blood monocytes. In contrast, numbers and CD33 expression were observed, whereas CD13 of CD14++ cells did not change compared to stable decreased, indicating specificity of glucocorticoid effect HD patients indicating that proinflammatory modulating the LPS-receptor antigen. Glucocorticoids CD14+/CD16+ monocytes were selectively selectively affected the CD14+/CD16+ subpopulation expanded. During acute infections, most of them being of monocytes not only by down-regulating CD14 due to vascular access problems (shunt infections, -expression (and HLA-DR) and release of sCD14 but infected jugular vein catheter) CD14+/CD16+ cells also by inducing a rapid decline of the amount of always are expanded (P<0.001).
circulating proinflammatory cells [7] . In addition, CD14+/CD16+ monocytes exhibited a significant 1,25-dihydroxyvitamin D 3 exhibits various immunomhigher phagocytosis rate for FITC-labelled than odulatory properties, regulates the synthesis of Escherichia coli CD14++/CD16 negative monocytes immunoglobulins, cytokines and TNF-a, and the underlining their role during host defence. In addition, expression of HLA-DR. Calcitriol enhances monocyte CD14+/CD16+ monocytes expressed higher levels of expression of CD14 and release of sCD14 cultured MHC class II antigens (HLA-DR, DP, DQ), and monocytes in a dose dependent manner [18] . Uraemic equal amounts of MHC class I. Thus, CD14+/CD16+ ultrafiltrate contains factors that impair calcitriol activcells constitute a potent phagocytosing and antigen-ated function of monocytes. Calcitriol supplementation presenting monocyte subpopulation, which is select-is capable of enhancing the phagocytic function of ively expanded in HD patients, and further increases monocytes and may prevent spontaneous and allergic during infections. Ultrapure dialysate may improve autoimmune diseases as well as graft rejection. monocyte alterations [15] .
CD14 and apoptosis

CD14 is engaged in the recognition and clearing of
Peritoneal dialysis
apoptotic cells without inducing inflammation [19] . The region of CD14 responsible for this interaction Studies on the phenotypic characterization of monocytes is closely associated with the LPS binding site. and peritoneal macrophages in CAPD patients revealed Up-regulation of CD14 (e.g. by LPS ) prevents a higher proportion of CD16 positive blood monocytes apoptosis, whereas down-modulation of CD14 (e.g. by and ICAM-1 expression compared to healthy controls IL-4) or shedding of CD14 promotes programmed cell [16 ] . Transmigration of monocytes into the peritoneal death. Thus, this newly detected function of CD14 cavity paralleled selective upregulation of the functional demonstrates that the 'LPS-receptor protein' is also receptors CD11b/CD18, CD11c/CD18, HLA-DR and involved in the regulation of monocyte senescence [20] . ICAM-1. The proportion of CD14/16 positive blood monocytes was higher in CAPD patients compared to Monocytes/macrophages and progressive renal that of HD patients [17] . Thus, factors other than disease:
membrane-cell interactions, complement activation and oxidative stress, characteristic for HD, may govern the pro-or microinflammatory status in CAPD (e.g. Under pathological conditions the influx of monocytes osmotic cell damage, influence of glycotoxins, bacterial into the kidney and local proliferation of blood derived macrophages releasing proinflammatory and fibrogenic transfer from the intestine).
cytokines contribute to structural and functional lysis water quality, b2-micro-globulin amyloidosis, deterioration. Tubulointerstitial kidney lesions may atherogenesis and accelerated cardiovascular morbidity. and apparently associated with bioincompatibility, dia-
